What is NDC 65862-199?

65862-199 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Aurobindo Pharma Limited. It has 9 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gabapentin NDC 65862-199 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-199Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0199Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65862-199-01	6586201990165862019901	100 CAPSULE in 1 BOTTLE (65862-199-01)Marketed from Jan 31, 2008
65862-199-05	6586201990565862019905	500 CAPSULE in 1 BOTTLE (65862-199-05)Marketed from Jan 31, 2008
65862-199-10	6586201991065862019910	10 BLISTER PACK in 1 CARTON (65862-199-10) / 10 CAPSULE in 1 BLISTER PACKMarketed from Jan 31, 2008
65862-199-18	6586201991865862019918	180 CAPSULE in 1 BOTTLE (65862-199-18)Marketed from Apr 29, 2021
65862-199-27	6586201992765862019927	270 CAPSULE in 1 BOTTLE (65862-199-27)Marketed from Apr 29, 2021
65862-199-30	6586201993065862019930	30 CAPSULE in 1 BOTTLE (65862-199-30)Marketed from Apr 29, 2021
65862-199-60	6586201996065862019960	60 CAPSULE in 1 BOTTLE (65862-199-60)Marketed from Apr 29, 2021
65862-199-90	6586201999065862019990	90 CAPSULE in 1 BOTTLE (65862-199-90)Marketed from Apr 29, 2021
65862-199-99	6586201999965862019999	1000 CAPSULE in 1 BOTTLE (65862-199-99)Marketed from Jan 31, 2008

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078787
Marketing start: Jan 31, 2008
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 65862-199_7a45ad84-02a4-442d-8401-1a1495d084faSPL ID 7a45ad84-02a4-442d-8401-1a1495d084faSPL set ID 1a619a14-0b63-4cba-80e7-474c9a1c90b9RxCUI 310430, 310431, 310432UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862019901 followed by a unit qualifier and the quantity

Package 65862-0199-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 12, 2025.

Indications (excerpt from the label)

Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin capsules are indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-199

What is NDC 65862-199?: 65862-199 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Aurobindo Pharma Limited. It has 9 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gabapentin?: 561 other product NDCs are listed under this name. See all Gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-00
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 Gabapentin NDCs

Other NDCs under ANDA 078787

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078787
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	NorthStar Rx LLC	16714-661
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	NorthStar Rx LLC	16714-662
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	NorthStar Rx LLC	16714-663
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	A-S Medication Solutions	50090-0949
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	A-S Medication Solutions	50090-1072
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	A-S Medication Solutions	50090-6718
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	A-S Medication Solutions	50090-6875
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Aurobindo Pharma Limited	65862-200
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Redpharm Drug	67296-2299
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-2911
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Proficient Rx LP	71205-295
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Proficient Rx LP	71205-373
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1484
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1655
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2699
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2700
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2748
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2773
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-126
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-188

Showing 20 of 23.